FACT and JACIE published version 5.3 of the International Standards for Cellular Therapy Product Collection, Processing, and Administration and its accompanying Cellular Therapy Accreditation Manual on August 21, 2013 to reflect FDA requirements for donor eligibility documentation. Specifically, this version removes the requirements for donor eligibility documentation for autologous donors in Appendix III. The updated Accreditation Manual also includes updated guidance on DMSO lot-to-lot qualification for Standard D4.13.2.
This version of the Standards becomes effective on September 20, 2013. 
FACT-JACIE International Standards for Cellular Therapy Product Collection, Processing, and Administration, version 5.3
FACT-JACIE Cellular Therapy Accreditation Manual, version 5.3

Ask FACT

FAQ

Ask a Peer
FACT Consulting

Accreditation Success Story

Hoxworth Blood Center Apheresis Collection Facility and its Cellular Therapies Division have been accredited by FACT since 2003. The program values their FACT accreditation and the impact it has had on their program’s continuous quality improvement objectives. Read more